Loomis Sayles & Co. L P Increases Stake in Privia Health Group, Inc. (NASDAQ:PRVA)

Loomis Sayles & Co. L P lifted its stake in Privia Health Group, Inc. (NASDAQ:PRVA) by 55.0% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,418,234 shares of the company’s stock after buying an additional 503,002 shares during the quarter. Loomis Sayles & Co. L P owned approximately 1.18% of Privia Health Group worth $27,727,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of PRVA. Riverbridge Partners LLC increased its holdings in Privia Health Group by 19.7% in the 4th quarter. Riverbridge Partners LLC now owns 5,824,458 shares of the company’s stock valued at $113,868,000 after acquiring an additional 958,418 shares during the last quarter. Eventide Asset Management LLC increased its holdings in shares of Privia Health Group by 979.2% in the third quarter. Eventide Asset Management LLC now owns 822,438 shares of the company’s stock worth $14,977,000 after purchasing an additional 746,231 shares during the last quarter. FMR LLC lifted its position in shares of Privia Health Group by 1.5% in the third quarter. FMR LLC now owns 18,169,043 shares of the company’s stock worth $330,858,000 after buying an additional 271,645 shares in the last quarter. JPMorgan Chase & Co. lifted its position in shares of Privia Health Group by 111.7% in the fourth quarter. JPMorgan Chase & Co. now owns 398,738 shares of the company’s stock worth $7,795,000 after buying an additional 210,354 shares in the last quarter. Finally, Barclays PLC boosted its stake in Privia Health Group by 240.3% during the third quarter. Barclays PLC now owns 224,018 shares of the company’s stock valued at $4,079,000 after buying an additional 158,188 shares during the last quarter. Institutional investors own 94.48% of the company’s stock.

Privia Health Group Stock Up 0.2 %

Shares of Privia Health Group stock opened at $22.92 on Friday. The stock’s fifty day moving average is $23.79 and its two-hundred day moving average is $21.13. Privia Health Group, Inc. has a 52 week low of $15.92 and a 52 week high of $26.04. The company has a market capitalization of $2.76 billion, a PE ratio of 229.22, a price-to-earnings-growth ratio of 3.47 and a beta of 0.85.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on PRVA shares. Canaccord Genuity Group upped their price objective on Privia Health Group from $29.00 to $30.00 and gave the stock a “buy” rating in a report on Friday, February 28th. JMP Securities set a $29.00 price target on shares of Privia Health Group in a research note on Friday, February 28th. Piper Sandler increased their price objective on shares of Privia Health Group from $25.00 to $40.00 and gave the company an “overweight” rating in a research report on Friday, February 28th. Needham & Company LLC restated a “buy” rating and issued a $30.00 target price on shares of Privia Health Group in a report on Friday, March 21st. Finally, Macquarie began coverage on shares of Privia Health Group in a report on Monday, December 16th. They issued an “outperform” rating and a $25.00 price target for the company. One analyst has rated the stock with a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Buy” and a consensus price target of $26.67.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.